These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1764162

  • 1. Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines.
    Facchetti I, Grandi M, Cucchi P, Geroni C, Penco S, Vigevani A.
    Anticancer Drug Des; 1991 Nov; 6(5):385-97. PubMed ID: 1764162
    [Abstract] [Full Text] [Related]

  • 2. Oxazolinodoxorubicin - a promising new anthracycline.
    Lukawska M, Klopotowska D, Milczarek M, Wietrzyk J, Studzian K, Szmigiero L, Porebska A, Oszczapowicz I.
    Anticancer Res; 2012 Jul; 32(7):2959-65. PubMed ID: 22753760
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro studies on anthracycline haloderivatives.
    Facchinetti T, Geroni C, Fumagalli A, Giuliani FC.
    Drugs Exp Clin Res; 1986 Jul; 12(8):657-61. PubMed ID: 3463498
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A, Liu LF, Israel M, Seshadri R, Koseki Y, Giuliani FC, Kirschenbaum S, Silber R, Potmesil M.
    Cancer Res; 1989 Nov 01; 49(21):5969-78. PubMed ID: 2551497
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Anthracycline transport in sensitive and resistant leukemia cells].
    Erttmann R, Erb N, Forcadell de Dios P, Neurath C, Looft G, Landbeck G.
    Klin Padiatr; 1989 Nov 01; 201(1):40-5. PubMed ID: 2704176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline.
    Broggini M, Grandi M, Ubezio P, Geroni C, Giuliani FC, D'Incalci M.
    Biochem Pharmacol; 1988 Dec 01; 37(23):4423-31. PubMed ID: 3202888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
    Zijlstra JG, Meijer C, Timmer-Bosscha H, Le TK, de Vries EG, Mulder NH.
    Eur J Respir Dis Suppl; 1987 Dec 01; 149():53-5. PubMed ID: 3034649
    [No Abstract] [Full Text] [Related]

  • 15. In vitro chemosensitivity testing using the multicellular tumor spheroid model.
    Kerr DJ, Wheldon TE, Kerr AM, Kaye SB.
    Cancer Drug Deliv; 1987 Dec 01; 4(2):63-74. PubMed ID: 3427553
    [Abstract] [Full Text] [Related]

  • 16. Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.
    Hofman J, Malcekova B, Skarka A, Novotna E, Wsol V.
    Toxicol Appl Pharmacol; 2014 Aug 01; 278(3):238-48. PubMed ID: 24832494
    [Abstract] [Full Text] [Related]

  • 17. Oxidized phospholipid based pH sensitive micelles for delivery of anthracyclines to resistant leukemia cells in vitro.
    Wang Y, Chen L, Ding Y, Yan W.
    Int J Pharm; 2012 Jan 17; 422(1-2):409-17. PubMed ID: 22037443
    [Abstract] [Full Text] [Related]

  • 18. Doxorubicin induces the acetylation of histone H1 in a human colon cancer cell line (LoVo/DX) selected for resistance to the drug, but not in the sensitive parental line (LoVo).
    Mannironi C, D'Incalci M.
    Biochem Biophys Res Commun; 1988 Sep 30; 155(3):1221-9. PubMed ID: 3178805
    [Abstract] [Full Text] [Related]

  • 19. Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.
    Gruber BM, Anuszewska EL, Bubko I, Goździk A, Fokt I, Priebe W.
    Arch Immunol Ther Exp (Warsz); 2007 Sep 30; 55(3):193-8. PubMed ID: 17557149
    [Abstract] [Full Text] [Related]

  • 20. Biologic properties of three anthracyclines as a function of lipophilicity.
    Kessel D.
    Biochem Pharmacol; 1979 Oct 01; 28(19):3028-30. PubMed ID: 518699
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.